Media Releases

2024

30/12/2024

It takes women seven years to be diagnosed with endometriosis. That could soon change – 9 News

17/12/2024

Proteomics $2.16m R&D rebate fuels breakthrough blood tests – The Sydney Morning Herald

23/09/2024

Proteomics reports positive results for PromarkerEso oesophageal cancer test – Medical Device Network

29/08/2024

Blood test for kidney decline in Type 1 diabetes – Medical Forum

23/08/2024

Proteomics testing pinpoints future kidney disease risks – The Age

21/08/2024

The Silent Killer: Prevention is the next cure – Phase III Podcast

20/08/2024

How Digital Health Infrastructure and Advanced Medical Devices Will Increase the Opportunity for Personalised Care – Medhealth Insight

08/07/2024

Shares In Value Interview with ASX: PIQ Managing Director

24/06/2024

Proteomics International Inks Deal With Eurobio Scientific for French Distribution of Kidney Test – 360Dx

24/06/2024

Proteomics seals kidney disease test supply deal in France – The West Australian

17/06/2024

Proteomics engages Growth Medics to expand PromarkerD test reach in EU – Medical Device Network

17/06/2024

Proteomics boosts European presence with diabetes device – The West Australian

24/05/2024

Dr Borehams’s Crucible: Proteomics International Labs – Biotech Daily

16/05/2024

Breakthrough in fight against chemically resistant dieback – Curtin University

16/05/2024

Proteomics tech emerges as early dieback diagnosis key

1
2
3
4
5
6
7
8
9
…
27